AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting ELEMENT--[Back to the Newsroom]# AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter ReportingCollaboration enables deployment of MaxYieldâ"¢ and CardioYieldâ"¢ into third-party health systems and clinic sitesThis pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG and Holter-style monitoring deploymentsTORONT ...

Engagement Supports Commercial Readiness Strategy for MaxYieldâ"¢ and CardioYieldâ"¢ in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that its wholly owned subsidiary, Neural Cloud Solutions Inc. ("Neural Cloud"), has entered into an agreement on February 9th, 2026 with Commission Wolf, a U.S.-based sales recruiting firm, to support the build-out of Neural Cloud's U.S. commercial ...

Core Insights - NeuralCloud Solutions Inc. has announced a strategic collaboration with Movesense Ltd to enhance cardiac monitoring solutions through the integration of wearable ECG devices and AI technology [1][2]. Group 1: Collaboration Overview - The partnership designates Movesense as a primary ECG device partner for NeuralCloud, focusing on developing bundled cardiac monitoring solutions [1]. - The collaboration aims to combine Movesense's wearable single-lead ECG sensors with NeuralCloud's AI-powered platforms, including MaxYield™, CardioYield™, and Insight360™, to improve ECG acquisition and reporting [2][4]. Group 2: Technology and Product Integration - Movesense's lightweight and programmable wearable sensors provide a flexible and cost-effective hardware foundation for ECG monitoring [3]. - The integration of Movesense's sensors with NeuralCloud's AI-driven signal processing allows for comprehensive ECG workflows that surpass traditional methods [3][4]. - Insight360™ offers customizable ECG reports through user-friendly dashboards, while CardioYield™ facilitates structured Holter-style reviews, and MaxYield™ enhances signal quality and data labeling [5]. Group 3: Market Position and Strategy - The collaboration aims to address markets traditionally served by higher-cost Holter monitoring systems, potentially offering more accessible alternatives [4]. - The partnership enhances operational and commercial flexibility, enabling faster deployment and broader market reach for combined hardware and software solutions [6]. - The collaboration reflects a strategic move to embed AI-powered cardiac intelligence into real-world workflows, strengthening the companies' market position [6].

Core Insights - NeuralCloud Solutions Inc. has initiated a pilot collaboration with Cornerstone Physiotherapy to enhance athlete performance through advanced analytics [1] - The collaboration focuses on integrating NeuralCloud's MaxYield signal-processing engine and Insight360 performance analytics into Cornerstone's elite athlete program [1] - Cornerstone is developing a physiotherapist-led performance program aimed at competitive Hyrox athletes, emphasizing evidence-based practices [1] Company Overview - NeuralCloud is a subsidiary of AI/ML Innovations Inc., listed on CSE, OTCQB, and FWB [1] - The company specializes in AI and machine learning solutions, particularly in the field of performance analytics [1] Industry Context - The partnership aims to extend the application of ECG analytics into the sports science and human performance markets [1] - The initiative reflects a growing trend in the sports industry towards data-driven performance enhancement and injury prevention [1]

Core Insights - NeuralCloud Solutions Inc. has entered into a non-binding Commercial Agreement with Equimetrics to integrate its AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance markets [1] Group 1: Company Developments - The agreement will expand NeuralCloud's MaxYield™ and CardioYield™ platforms into Equimetrics' V-PRO Clinical Monitoring and S-PRO Sports Performance product lines [1] - This collaboration aims to enhance the veterinary and equine health sector by providing AI-driven ECG signal processing for better performance optimization and cardiac safety [1] Group 2: Market Impact - The integration of advanced ECG technology is expected to enable higher-fidelity and automated interpretation of electrocardiograms (ECG) [1]

Core Insights - The article highlights the validation of AIML's innovative neural-network method for denoising and mapping ECG signals, which supports the functionality of its products MaxYield™ and CardioYield™ [1] - This validation strengthens the company's competitive edge as it progresses in commercialization and regulatory processes [1] Company Summary - AIML has developed a novel approach utilizing neural networks for ECG signal processing, which is crucial for its product offerings [1] - The successful validation of this technology is expected to enhance the company's market position and facilitate its growth in the healthcare technology sector [1] Industry Summary - The advancements in AI and machine learning applications in healthcare, particularly in ECG signal processing, are becoming increasingly significant [1] - Companies focusing on innovative solutions in medical technology are likely to gain a competitive advantage as regulatory pathways evolve [1]

Core Insights - ThreeD Capital Inc. congratulates AI/ML Innovations Inc. on signing a Letter of Intent with Circular Health Limited to integrate and license Neural Cloud's ECG signal-processing platform, MaxYield™ [1][2] - The integration phase will involve deploying MaxYield through a cloud-based API, with a target for commercial launch by September 2025 [2] - ThreeD Capital holds 20,899,200 common shares and 27,000,000 common share purchase warrants of AIML, indicating a significant investment in the company [2] Company Overview - ThreeD Capital is a Canadian-based venture capital firm focused on opportunistic investments in junior resources and disruptive technologies sectors [4] - The investment strategy includes investing in multiple private and public companies globally, particularly in early-stage promising companies [4] - The firm aims to be a lead investor and provide advisory services and access to its ecosystem for investees [4]